Literature DB >> 9308368

Molecular and structural features of the proton-coupled oligopeptide transporter superfamily.

Y J Fei1, V Ganapathy, F H Leibach.   

Abstract

Work in the area of molecular biology of transport proteins has unveiled the presence of a distinct peptide transporter superfamily whose members extend from the prokaryotic to the eukaryotic kingdom. There are two subgroups within this superfamily, one subgroup harnessing the energy necessary for active transport from a transmembrane H+ gradient and the other subgroup relying directly on ATP hydrolysis. In addition to the use of different driving forces, the two subgroups are also distinguishable with regard to molecular structure and operational mechanism. This review is intended to analyze critically the molecular nature of the members of the H+ gradient-dependent peptide transporter subgroup, with emphasis on the cloning strategies utilized in the isolation of the individual transporter cDNAs or genes; on the structural patterns, motifs, and conserved amino acid residues common to constituent members of the subgroup; and on the characteristic topological features of the individual members.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9308368     DOI: 10.1016/s0079-6603(08)60038-0

Source DB:  PubMed          Journal:  Prog Nucleic Acid Res Mol Biol        ISSN: 0079-6603


  11 in total

1.  Cloning of a lymphatic peptide/histidine transporter.

Authors:  K Sakata; T Yamashita; M Maeda; Y Moriyama; S Shimada; M Tohyama
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

2.  Two oligopeptide transporters from Caenorhabditis elegans: molecular cloning and functional expression.

Authors:  Y J Fei; T Fujita; D F Lapp; V Ganapathy; F H Leibach
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

3.  Functional Characterization of Human Peptide/Histidine Transporter 1 in Stably Transfected MDCK Cells.

Authors:  Feifeng Song; Yongjun Hu; Yuqing Wang; David E Smith; Huidi Jiang
Journal:  Mol Pharm       Date:  2018-01-02       Impact factor: 4.939

4.  Human proton/oligopeptide transporter (POT) genes: identification of putative human genes using bioinformatics.

Authors:  C W Botka; T W Wittig; R C Graul; C U Nielsen; K Higaka; G L Amidon; W Sadée
Journal:  AAPS PharmSci       Date:  2000

5.  Phenotype analysis of mice deficient in the peptide transporter PEPT2 in response to alterations in dietary protein intake.

Authors:  Isabelle M Frey; Isabel Rubio-Aliaga; Martina Klempt; Eckhard Wolf; Hannelore Daniel
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

6.  4-aminomethylbenzoic acid is a non-translocated competitive inhibitor of the epithelial peptide transporter PepT1.

Authors:  D Meredith; C A Boyd; J R Bronk; P D Bailey; K M Morgan; I D Collier; C S Temple
Journal:  J Physiol       Date:  1998-11-01       Impact factor: 5.182

Review 7.  Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity.

Authors:  Mohamed A Kamal; Richard F Keep; David E Smith
Journal:  Drug Metab Pharmacokinet       Date:  2008       Impact factor: 3.614

8.  PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.

Authors:  Guillaume Dalmasso; Laetitia Charrier-Hisamuddin; Hang Thi Thu Nguyen; Yutao Yan; Shanthi Sitaraman; Didier Merlin
Journal:  Gastroenterology       Date:  2007-10-17       Impact factor: 22.682

9.  Targeted disruption of the peptide transporter Pept2 gene in mice defines its physiological role in the kidney.

Authors:  Isabel Rubio-Aliaga; Isabelle Frey; Michael Boll; David A Groneberg; Hans M Eichinger; Rudi Balling; Hannelore Daniel
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

10.  Butyrate transcriptionally enhances peptide transporter PepT1 expression and activity.

Authors:  Guillaume Dalmasso; Hang Thi Thu Nguyen; Yutao Yan; Laetitia Charrier-Hisamuddin; Shanthi V Sitaraman; Didier Merlin
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.